Evens AM - Search Results

1

Multicenter Phase II Study of Sequential Brentuximab Vedotin and Doxorubicin, Vinblastine, and Dacarbazine Chemotherapy for Older Patients With Untreated Classical Hodgkin Lymphoma.

Evens AM, Advani RH, Helenowski IB, Fanale M, Smith SM, Jovanovic BD, Bociek GR, Klein AK, Winter JN, Gordon LI, Hamlin PA. Evens AM, et al. J Clin Oncol. 2018 Oct 20;36(30):3015-3022. doi: 10.1200/JCO.2018.79.0139. Epub 2018 Sep 4. J Clin Oncol. 2018. PMID: 30179569 Clinical Trial.

2

Burkitt's and Burkitt-like lymphoma.

Evens AM, Gordon LI. Evens AM, et al. Curr Treat Options Oncol. 2002 Aug;3(4):291-305. doi: 10.1007/s11864-002-0029-9. Curr Treat Options Oncol. 2002. PMID: 12074766 Review.

3

Expression of the candidate MCT-1 oncogene in B- and T-cell lymphoid malignancies.

Shi B, Hsu HL, Evens AM, Gordon LI, Gartenhaus RB. Shi B, et al. Among authors: evens am. Blood. 2003 Jul 1;102(1):297-302. doi: 10.1182/blood-2002-11-3486. Epub 2003 Mar 13. Blood. 2003. PMID: 12637315 Free article.

4

Imexon-induced apoptosis in multiple myeloma tumor cells is caspase-8 dependent.

Evens AM, Prachand S, Shi B, Paniaqua M, Gordon LI, Gartenhaus RB. Evens AM, et al. Clin Cancer Res. 2004 Feb 15;10(4):1481-91. doi: 10.1158/1078-0432.ccr-1058-03. Clin Cancer Res. 2004. PMID: 14977852

5

Treatment of T-cell non-Hodgkin's lymphoma.

Evens AM, Gartenhaus RB. Evens AM, et al. Curr Treat Options Oncol. 2004 Aug;5(4):289-303. doi: 10.1007/s11864-004-0020-8. Curr Treat Options Oncol. 2004. PMID: 15233906 Review.

6

Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress.

Evens AM, Mehta J, Gordon LI. Evens AM, et al. Bone Marrow Transplant. 2004 Oct;34(7):561-71. doi: 10.1038/sj.bmt.1704591. Bone Marrow Transplant. 2004. PMID: 15286699 Review.

7

Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cells.

Evens AM, Lecane P, Magda D, Prachand S, Singhal S, Nelson J, Miller RA, Gartenhaus RB, Gordon LI. Evens AM, et al. Blood. 2005 Feb 1;105(3):1265-73. doi: 10.1182/blood-2004-03-0964. Epub 2004 Sep 23. Blood. 2005. PMID: 15388578 Free article.

8

Radioimmunotherapy in non-Hodgkin's lymphoma: trials of yttrium 90-labeled ibritumomab tiuxetan and beyond.

Evens AM, Gordon LI. Evens AM, et al. Clin Lymphoma. 2004 Oct;5 Suppl 1:S11-5. doi: 10.3816/clm.2004.s.003. Clin Lymphoma. 2004. PMID: 15498144 Review.

9

Can the stem cell mobilization technique influence CD34+ cell collection efficiency of leukapheresis procedures in patients with hematologic malignancies?

Gidron A, Verma A, Doyle M, Boggio L, Evens A, Gordon L, Singhal S, Tallman M, Williams S, Winter J, Mehta J. Gidron A, et al. Bone Marrow Transplant. 2005 Feb;35(3):243-6. doi: 10.1038/sj.bmt.1704781. Bone Marrow Transplant. 2005. PMID: 15580281

10

Motexafin gadolinium induces oxidative stress and apoptosis in hematologic malignancies.

Evens AM, Balasubramanian L, Gordon LI. Evens AM, et al. Curr Treat Options Oncol. 2005 Jul;6(4):289-96. doi: 10.1007/s11864-005-0033-y. Curr Treat Options Oncol. 2005. PMID: 15967082 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page